Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Figure 1.

Screening the Microsource GenPlus chemical library against E. coli DNA gyrase and M. mazei DNA topoisomerase VI.

A. Results from the DNA gyrase screen. B. Results from the topoisomerase VI screen. Each bar represents the average percentage inhibition for a compound screened in duplicate. Compound bars have been coloured to indicate 96-well plate groupings. The arbitrary hit threshold of 25% inhibition is demonstrated by the dotted lines.

More »

Figure 1 Expand

Figure 2.

Structures of screen hits.

The M. mazei topo VI inhibitors are circled in blue on the left and the DNA gyrase inhibitors are circled in purple on the right. The 11 already well characterised inhibitors of DNA gyrase identified by the screen are not shown.

More »

Figure 2 Expand

Table 1.

Summary of Screen Hits.

More »

Table 1 Expand

Figure 3.

In vitro characterisation of DNA gyrase screen hits.

A. Determination of the IC50 for mitoxantrone in a supercoiling assay with 1 unit of gyrase (12 nM); 100 μM ciprofloxacin (Cip.) was used as a positive control for inhibition. The positions of relaxed (Rel.) and negatively supercoiled (SC) DNA are indicated. B. Determination of the IC50 for suramin. C. Assaying the abilities of mitoxantrone and suramin to induce gyrase-mediated DNA cleavage. The reactions were carried out in the absence of ATP. Ciprofloxacin was used as a positive control for gyrase-mediated cleavage. The position of linear DNA (Lin.) is indicated. D. Suramin-induced protection of DNA from Ca2+-induced, gyrase-mediated cleavage. E. Inhibition of gyrase binding to a 147 bp DNA fragment by suramin.

More »

Figure 3 Expand

Figure 4.

Growth of M. smegmatis mc2155 in the presence of mitoxantrone or suramin.

A. Bacteria were grown in liquid cultures in the presence of drug for 22 hours, and then plated onto drug-free agar. After a further 48 h the colonies were counted for each concentration of drug. B. Colony counts for bacteria grown in the presence of 0, 13 or 65 µM mitoxantrone for 16, 19 or 22 hours before being plated onto solid media.

More »

Figure 4 Expand

Figure 5.

In vitro characterisation of topoisomerase VI screen hits.

A. Determination of IC50 values for hits in the presence of 1 unit (50 nM) of M. mazei topo VI. This resulted in the following IC50 values: 6 μM for 9-aminoacridne; 30 μM for m-amsacrine; 30 μM for suramin; 30 μM for hexylresorcinol; 40 μM for purpurin; 8 μM for quinacrine; and 2 μM for mitoxanthrone. B. Native gel shift assays for the binding of M. mazei topo VI to a 147 bp DNA fragment in the presence of screen hits.

More »

Figure 5 Expand

Figure 6.

DNA cleavage assays with topoisomerase VI screen hits.

A. Assaying the abilities of screen hits to induce M. mazei topo VI-mediated DNA cleavage with 1 unit topo VI (50 nM). B. Inhibition of S. shibatae topo VI by screen hits. C. Assaying the abilities of screen hits to induce S. shibatae topo VI-mediated DNA cleavage. D. Protection of DNA from ADPNP-induced, S. shibatae topo VI-mediated cleavage by screen hits.

More »

Figure 6 Expand

Figure 7.

Inhibition of Arabidopsis hypocotyl extension by hexylresorcinol.

All plants were grown for 5 days in the dark. A. Average length of seedlings grown on 20, 30, 40 50, 80 or 100 µM hexylresorcinol. Error bars represent the standard deviation of the samples. B. Percentage germination of seedlings grown on 20, 30, 40 50, 80 or 100 µM hexylresorcinol.

More »

Figure 7 Expand

Figure 8.

Activity of hexylresorcinol on Arabidopsis thaliana col-0.

A. Hypocotyl extension assay (1 mm scale bars). Left: control plant grown in the absence of hexylresorcinol. Centre: plant grown on 40 μM hexylresorcinol exhibiting normal morphology. Right: plant grown on 40 μM hexylresorcinol exhibiting dwarf morphology. B. Cyro-electron microscopy images of hypocotyls (100 μm white scale bar). Top: control plant grown in absence of hexylresorcinol. Middle: plant grown on 40 μM hexylresorcinol exhibiting normal morphology. Bottom: plant grown on 40 μM hexylresorcinol exhibiting dwarf morphology. C. Three-week-old Arabidopsis plants grown on 40 μM hexylresorcinol. A control plate which did not contain the compound was also included. Photos at a higher magnification were taken of plants displaying different morphologies. Plants 2, 5 and 7 displayed the “dwarf” morphology, whilst plants 1 and 6 were similar to the control in appearance. Plants 3 and 4 appeared intermediate in morphology. All hexylresorcinol-grown plants appeared somewhat transparent compared to the control plants.

More »

Figure 8 Expand